Niagen Bioscience (NAGE) Current Assets (2011 - 2026)

Niagen Bioscience (NAGE) has 14 years of Current Assets data on file, last reported at $105.1 million in Q1 2026.

• On a quarterly basis, Current Assets rose 37.92% year-over-year to $105.1 million in Q1 2026; TTM through Mar 2026 was $105.1 million, a 37.92% increase from a year earlier, with the FY2025 full-year figure at $96.8 million, up 51.02% from the prior year.
• Current Assets for Q1 2026 stood at $105.1 million, up from $96.8 million in the prior quarter.
• Over the last five years, Current Assets for NAGE reached as high as $105.1 million in Q1 2026 and fell as low as $37.9 million in Q3 2022.
• Historically, Current Assets has averaged $60.6 million across 5 years, with a median of $49.3 million in 2024.
• Across the five-year window, Current Assets plunged 33.53% in 2022 and soared 79.57% in 2025, its largest moves.
• Year by year, Current Assets stood at $46.6 million in 2022, then grew by 6.37% to $49.5 million in 2023, then climbed by 29.41% to $64.1 million in 2024, then soared by 51.02% to $96.8 million in 2025, then climbed by 8.59% to $105.1 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $105.1 million in Q1 2026, $96.8 million in Q4 2025, and $93.6 million in Q3 2025.